Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time
go back to main search page
Accession:CMO:0003503 term browser browse the term
Definition:The number of individuals in a study population which develop new instances of cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time compared to the total number of individuals in the study population with no beta-amyloid deposits, expressed as a percentage.
Synonyms:exact_synonym: cerebral small perivascular bleeds and no beta-amyloid deposits incidence;   percentage of study population developing cerebral microhemorrhages and no beta-amyloid deposits during a period of time
 xref: ISBN:978-1416049982


show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time" (CMO:0003503)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        nervous system disease incidence/prevalence measurement 25
          cerebrovascular lesion incidence/prevalence measurement 4
            percentage of study population developing cerebrovascular lesions during a period of time 4
              percentage of study population developing cerebral small perivascular bleeds during a period of time 0
                percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    nervous system measurement 63
      central nervous system measurement 29
        brain measurement 18
          brain lesion measurement 8
            brain non-tumorous lesion measurement 8
              cerebrovascular lesion measurement 7
                cerebrovascular lesion incidence/prevalence measurement 4
                  percentage of study population developing cerebrovascular lesions during a period of time 4
                    percentage of study population developing cerebral small perivascular bleeds during a period of time 0
                      percentage of study population developing cerebral small perivascular bleeds and no beta-amyloid deposits during a period of time 0
paths to the root